Cleveland-Cliffs Inc
F:CVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
Basf Se
MIL:1BAS
|
DE |
|
M
|
Mckesson Corp
XMUN:MCK
|
US |
|
T
|
Tamarack Valley Energy Ltd
F:9TA1
|
CA |
|
F
|
Funko Inc
SWB:FU2
|
US |
Wall St Price Targets
CVA Price Targets Summary
Cleveland-Cliffs Inc
According to Wall Street analysts, the average 1-year price target for
CVA is 14.7 EUR with a low forecast of 9.65 EUR and a high forecast of 18.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CVA's stock price target?
Price Target
14.7
EUR
According to Wall Street analysts, the average 1-year price target for
CVA is 14.7 EUR with a low forecast of 9.65 EUR and a high forecast of 18.82 EUR.
What is the Revenue forecast for Cleveland-Cliffs Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 5%.